1. Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.

    The Spine Journal 15(4):692 (2015) PMID 25523380

    Use of bone morphogenetic protein (BMP) as an adjunct to spinal fusion surgery proliferated after Food and Drug Administration (FDA) approval in 2002. Major safety concerns emerged in 2008. The purpose of this study was to examine whether published concerns about the safety of BMP altered clinic...
  2. Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.

    The Spine Journal 15(4):692 (2015) PMID 25523380 PMCID PMC4375057

    Use of bone morphogenetic protein (BMP) as an adjunct to spinal fusion surgery proliferated after Food and Drug Administration (FDA) approval in 2002. Major safety concerns emerged in 2008. The purpose of this study was to examine whether published concerns about the safety of BMP altered clinic...
  3. Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.

    The Spine Journal 15(4):692 (2015) PMID 25523380

    Use of bone morphogenetic protein (BMP) as an adjunct to spinal fusion surgery proliferated after Food and Drug Administration (FDA) approval in 2002. Major safety concerns emerged in 2008. The purpose of this study was to examine whether published concerns about the safety of BMP altered clinic...
  4. Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.

    The Spine Journal 15(4):692 (2015) PMID 25523380 PMCID PMC4375057

    Use of bone morphogenetic protein (BMP) as an adjunct to spinal fusion surgery proliferated after Food and Drug Administration (FDA) approval in 2002. Major safety concerns emerged in 2008. The purpose of this study was to examine whether published concerns about the safety of BMP altered clinic...
  5. Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.

    The Spine Journal 15(4):692 (2015) PMID 25523380 PMCID PMC4375057

    Use of bone morphogenetic protein (BMP) as an adjunct to spinal fusion surgery proliferated after Food and Drug Administration (FDA) approval in 2002. Major safety concerns emerged in 2008. The purpose of this study was to examine whether published concerns about the safety of BMP altered clinic...
  6. Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.

    The Spine Journal 15(4):692 (2015) PMID 25523380 PMCID PMC4375057

    Use of bone morphogenetic protein (BMP) as an adjunct to spinal fusion surgery proliferated after Food and Drug Administration (FDA) approval in 2002. Major safety concerns emerged in 2008. The purpose of this study was to examine whether published concerns about the safety of BMP altered clinic...
  7. Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.

    The Spine Journal 15(4):692 (2015) PMID 25523380

    Use of bone morphogenetic protein (BMP) as an adjunct to spinal fusion surgery proliferated after Food and Drug Administration (FDA) approval in 2002. Major safety concerns emerged in 2008. The purpose of this study was to examine whether published concerns about the safety of BMP altered clinic...
  8. Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.

    The Spine Journal 15(4):692 (2015) PMID 25523380

    Use of bone morphogenetic protein (BMP) as an adjunct to spinal fusion surgery proliferated after Food and Drug Administration (FDA) approval in 2002. Major safety concerns emerged in 2008. The purpose of this study was to examine whether published concerns about the safety of BMP altered clinic...
  9. Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.

    The Spine Journal 15(4):692 (2015) PMID 25523380

    Use of bone morphogenetic protein (BMP) as an adjunct to spinal fusion surgery proliferated after Food and Drug Administration (FDA) approval in 2002. Major safety concerns emerged in 2008. The purpose of this study was to examine whether published concerns about the safety of BMP altered clinic...
  10. Association of early imaging for back pain with clinical outcomes in older adults.

    JAMA 313(11):1143 (2015) PMID 25781443

    In contrast to the recommendations for younger adults, many guidelines allow for older adults with back pain to undergo imaging without waiting 4 to 6 weeks. However, early imaging may precipitate interventions that do not improve outcomes. To compare function and pain at the 12-month follow-up ...
  11. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop.

    Annals of Internal Medicine 162(4):276 (2015) PMID 25581257

    Increases in prescriptions of opioid medications for chronic pain have been accompanied by increases in opioid overdoses, abuse, and other harms and uncertainty about long-term effectiveness. To evaluate evidence on the effectiveness and harms of long-term (>3 months) opioid therapy for chronic ...
  12. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop.

    Annals of Internal Medicine 162(4):276 (2015) PMID 25581257

    Increases in prescriptions of opioid medications for chronic pain have been accompanied by increases in opioid overdoses, abuse, and other harms and uncertainty about long-term effectiveness. To evaluate evidence on the effectiveness and harms of long-term (>3 months) opioid therapy for chronic ...
  13. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.

    Annals of Internal Medicine 162(4):276 (2015) PMID 25581257

    Increases in prescriptions of opioid medications for chronic pain have been accompanied by increases in opioid overdoses, abuse, and other harms and uncertainty about long-term effectiveness. To evaluate evidence on the effectiveness and harms of long-term (>3 months) opioid therapy for chronic ...
  14. Report of the NIH Task Force on research standards for chronic low back pain.

    Physical Therapy 95(2):e1 (2015) PMID 25639530

    Despite rapidly increasing intervention, functional disability due to chronic low back pain (cLBP) has increased in recent decades. We often cannot identify mechanisms to explain the major negative impact cLBP has on patients' lives. Such cLBP is often termed non-specific and may be due to multi...
  15. Report of the NIH Task Force on research standards for chronic low back pain.

    Physical Therapy 95(2):e1 (2015) PMID 25639530

    Despite rapidly increasing intervention, functional disability due to chronic low back pain (cLBP) has increased in recent decades. We often cannot identify mechanisms to explain the major negative impact cLBP has on patients' lives. Such cLBP is often termed non-specific and may be due to multi...
  16. Fusion surgery for lumbar degenerative disc disease: still more questions than answers.

    The Spine Journal 15(2):272 (2015) PMID 25598279

    Yoshihara H, Yoneoka D. National trends in the surgical treatment for lumbar degenerative disc disease: United States, 2000 to 2009. Spine J 2015;15:265-71 (in this issue). Copyright © 2015 Elsevier Inc. All rights reserved.
  17. Fusion surgery for lumbar degenerative disc disease: still more questions than answers.

    The Spine Journal 15(2):272 (2015) PMID 25598279

    Yoshihara H, Yoneoka D. National trends in the surgical treatment for lumbar degenerative disc disease: United States, 2000 to 2009. Spine J 2015;15:265-71 (in this issue). Copyright © 2015 Elsevier Inc. All rights reserved.
  18. Fusion surgery for lumbar degenerative disc disease: still more questions than answers.

    The Spine Journal 15(2):272 (2015) PMID 25598279

    Yoshihara H, Yoneoka D. National trends in the surgical treatment for lumbar degenerative disc disease: United States, 2000 to 2009. Spine J 2015;15:265-71 (in this issue). Copyright © 2015 Elsevier Inc. All rights reserved.
  19. Report of the NIH Task Force on Research Standards for Chronic Low Back Pain.

    Physical Therapy 95(2):e1 (2015) PMID 25639530

    Despite rapidly increasing intervention, functional disability due to chronic low back pain (cLBP) has increased in recent decades. We often cannot identify mechanisms to explain the major negative impact cLBP has on patients' lives. Such cLBP is often termed non-specific and may be due to multi...
  20. Opioids for low back pain.

    British Medical Journal (Abstracts) 350:g6380 (2015) PMID 25561513

    Back pain affects most adults, causes disability for some, and is a common reason for seeking healthcare. In the United States, opioid prescription for low back pain has increased, and opioids are now the most commonly prescribed drug class. More than half of regular opioid users report back pai...